Robert Francis emphasizes that while many portrayals of schizophrenia focus on positive symptoms like hallucinations, the negative symptoms, known as the 'A's of schizophrenia, are often more debilitating for those who live with the condition.
Dr. Gregory Strauss, highlighting the potential of Roluperidone, notes that this new drug could represent a paradigm shift, as it acts on serotonin receptors rather than dopamine, which may lead to more effective treatment of negative symptoms.
Collection
[
|
...
]